|
⚲
|
| Keyboard |
| Dorsey Brian
✚
|
|
|---|---|
| CIK # | 0001380762 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001380762] | |
| 4 | [0001380762] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Dorsey Brian | |
| ARS Pharmaceuticals Inc | |
| Seelos Therapeutics Inc | |
| Pernix Therapeutics Holdings Inc | |
| Pernix Sleep Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
ARS Pharmaceuticals Inc SPRY
Stock option (right to buy) · derivative
|
2026-01-02 | Grant | 240,000 | $0.00 | |
|
ARS Pharmaceuticals Inc SPRY
Common Stock
|
2025-11-13 | Sell | 21,828 | $8.71 | 190,122 |
|
ARS Pharmaceuticals Inc SPRY
Stock Option (Right to Buy) · derivative
|
2025-11-13 | Option exercise | 21,828 | $0.00 | |
|
ARS Pharmaceuticals Inc SPRY
Common Stock
|
2025-11-13 | Option exercise | 21,828 | $0.64 | 13,970 |
|
ARS Pharmaceuticals Inc SPRY
Stock option (right to buy) · derivative
|
2025-01-02 | Grant | 261,900 | $0.00 | |
|
ARS Pharmaceuticals Inc SPRY
Common Stock
|
2024-12-12 | Option exercise | 25,000 | $0.64 | 16,000 |
|
ARS Pharmaceuticals Inc SPRY
Common Stock
|
2024-12-12 | Sell | 25,000 | $12.30 | 307,500 |
|
ARS Pharmaceuticals Inc SPRY
Stock Option (Right to Buy) · derivative
|
2024-12-12 | Option exercise | 25,000 | $0.00 | |
|
ARS Pharmaceuticals Inc SPRY
Stock Option (Right to Buy) · derivative
|
2024-12-11 | Option exercise | 15,000 | $0.00 | |
|
ARS Pharmaceuticals Inc SPRY
Common Stock
|
2024-12-11 | Sell | 15,000 | $12.43 | 186,450 |
|
ARS Pharmaceuticals Inc SPRY
Common Stock
|
2024-12-11 | Option exercise | 15,000 | $0.64 | 9,600 |
|
ARS Pharmaceuticals Inc SPRY
Stock Option (Right to Buy) · derivative
|
2024-08-20 | Option exercise | 50,000 | $0.00 | |
|
ARS Pharmaceuticals Inc SPRY
Common Stock
|
2024-08-20 | Option exercise | 50,000 | $0.64 | 32,000 |
|
ARS Pharmaceuticals Inc SPRY
Common Stock
|
2024-08-20 | Sell | 50,000 | $15.00 | 750,000 |
|
ARS Pharmaceuticals Inc SPRY
Stock Option (Right to Buy) · derivative
|
2024-08-13 | Option exercise | 30,000 | $0.00 | |
|
ARS Pharmaceuticals Inc SPRY
Common Stock
|
2024-08-13 | Option exercise | 30,000 | $0.64 | 19,200 |
|
ARS Pharmaceuticals Inc SPRY
Common Stock
|
2024-08-13 | Sell | 30,000 | $13.00 | 390,000 |
|
ARS Pharmaceuticals Inc SPRY
Stock option (right to buy) · derivative
|
2024-01-02 | Grant | 350,000 | $0.00 | |
|
ARS Pharmaceuticals Inc SPRY
Stock option (right to buy) · derivative
|
2023-01-03 | Grant | 145,000 | $0.00 | |
|
Seelos Therapeutics Inc APRI
Common Stock
|
2018-08-30 | Option exercise | 81,775 | ||
| showing 20 of 44 most recent transactions | |||||